Evidence mapPaperPMID 37855283Full record

ArticleEndocrine, metabolic & immune disorders drug targets2024

Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric and Mapping Analysis.

Yuling Song, Boru Chen, Lu Jiang, Fangkun Zhao, Xiuqin Feng

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, metabolic & immune disorders drug targets, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuling SongThe Fourth Affiliated Hospital of China Medical University, Shenyang, 110000, Liaoning, China.
Boru ChenThe Fourth Affiliated Hospital of China Medical University, Shenyang, 110000, Liaoning, China.
Lu JiangThe Fourth Affiliated Hospital of China Medical University, Shenyang, 110000, Liaoning, China.
Fangkun ZhaoThe Fourth Affiliated Hospital of China Medical University, Shenyang, 110000, Liaoning, China.
Xiuqin FengThe Fourth Affiliated Hospital of China Medical University, Shenyang, 110000, Liaoning, China.

Funding

Higher Education Institutions Scientific Research Project of Liaoning Province Grant No. LJKZ0773Medical Science and Technology Project of Zhejiang Province Grant No. 2021KY157
6 · The paper itself

Abstract

aimThe present study aimed to map publication trends and explore research hotspots of treatment for NAFLD study by bibliometric analysis.

backgroundNonalcoholic fatty liver disease (NAFLD) is a multi-system metabolic disorder involving the liver. Thousands of papers have been published on the treatment of NAFLD, but no comprehensive statistical and intuitive analysis has been made. The present study aimed to map publication trends and explore research hotspots of treatment for NAFLD study by bibliometric analysis.

objective(1) The pathogenesis of NAFLD and the possible treatment mechanism; (2) prevalence, risk factors, and traditional therapies for NAFLD; (3) frontier therapies for NAFLD. Method; This paper conducted a bibliometric analysis based on the Web of Science Core Collection (WoSCC). The knowledge map was constructed by VOS viewer v.1.6.10 to visualize the annual publication number, the distribution of countries, international collaborations, author productivity, source journals, cited references, and keywords in this field.

resultsFrom 2012 to 2021, 2,437 peer-reviewed publications on the treatment of NAFLD were retrieved. China contributed the most publications, while the United States received the most citations. Journal of Hepatology was the most prolific journal in this field. Prof. Rohit Loomba.

conclusionOur study provides a comprehensive and objective analysis of NAFLD treatment that allows researchers to quickly locate research hotspots in a large number of relevant literatures. Meanwhile, it may also provide valuable information for researchers looking for potential partners and institutions.

Indexed as

BibliometricsNon-alcoholic Fatty Liver DiseaseBiomedical ResearchHumansPeriodicals as Topicbibliometric analysisnAFLDNon-alcoholic fatty liver diseasetreatmentvOS viewerwoSCC.

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.